Literature DB >> 34047205

Role of nutritional care and general guidance for patients with advanced or metastatic gastric cancer.

Takuro Mizukami1, Yongzhe Piao2.   

Abstract

Patients with advanced or metastatic gastric cancer often suffer from malnutrition, which can have an impact on quality of life, increase the toxicity of chemotherapy and reduce overall survival. Options available to the clinician to manage a patient's nutritional status include screening and assessment of malnutrition at diagnosis, monitoring during the 'cancer journey', early detection of precachexia and the ongoing use of a multidisciplinary team (oncologists, other medical specialists and nutritionists). Because malnutrition is frequently overlooked and under treated in patients with advanced or metastatic gastric cancer, this narrative review focuses on the clinical meaning of nutritional status in gastric cancer and provides general guidance regarding nutritional care management for patients with advanced or metastatic gastric cancer.

Entities:  

Keywords:  cachexia; gastric cancer; malnutrition; nutritional care

Mesh:

Year:  2021        PMID: 34047205     DOI: 10.2217/fon-2021-0186

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  5 in total

1.  Nutritional Risk Index as a Prognostic Factor Predicts the Clinical Outcomes in Patients With Stage III Gastric Cancer.

Authors:  Haibin Song; Hongkai Sun; Laishou Yang; Hongyu Gao; Yongkang Cui; Chengping Yu; Haozhi Xu; Linqiang Li
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

2.  Correlation Between Components of Malnutrition Diagnosed by Global Leadership Initiative on Malnutrition Criteria and the Clinical Outcomes in Gastric Cancer Patients: A Propensity Score Matching Analysis.

Authors:  Li-Bin Xu; Ting-Ting Mei; Yi-Qi Cai; Wen-Jing Chen; Si-Xin Zheng; Liang Wang; Xiao-Dong Chen; Yun-Shi Huang
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

3.  Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines.

Authors:  Jishu Gu; Xuejiao Ni; Jinfeng Ji; Guohua Wei; Lei Shi; Chunming Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-27       Impact factor: 2.650

4.  Comparison of the Suitability Between NRS2002 and MUST as the First-Step Screening Tool for GLIM Criteria in Hospitalized Patients With GIST.

Authors:  Xin Zhou; Junjin Liu; Qijuan Zhang; Siqi Rao; Xingye Wu; Jun Zhang; Juan Li
Journal:  Front Nutr       Date:  2022-04-11

5.  Expression of miR-4739 in Gastric cancer and its Relationship with Clinical Pathological Features of Patients.

Authors:  Jiaxing Wei; Jun Li; Dong Geng; Yiling Peng; Bin Yang; Huixian Wu; Yun Zhou
Journal:  Front Surg       Date:  2022-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.